Eton Pharmaceuticals (ETON) EPS (Basic) Growth (3y) (2021 - 2026)
Eton Pharmaceuticals (ETON) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 32.44 Bn | 30.77 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.97 Bn | 18.09 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.16 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.70 Bn | 1.68 Bn | 25.41 Mn | 32.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.98% |
| Dec 31, 2025 | -17.34% |
| Sep 30, 2025 | 15.80% |
| Jun 30, 2025 | 98.84% |
| Mar 31, 2025 | 34.77% |
| Dec 31, 2024 | -36.80% |
| Sep 30, 2024 | 367.86% |
| Jun 30, 2024 | -1,038.39% |
| Mar 31, 2024 | -434.22% |
| Dec 31, 2023 | 41.65% |
| Sep 30, 2023 | 58.23% |
| Jun 30, 2023 | 26.01% |
| Mar 31, 2023 | 40.66% |
| Dec 31, 2022 | 39.85% |
| Sep 30, 2022 | 24.39% |
| Jun 30, 2022 | -596.88% |
| Mar 31, 2022 | 20.76% |
| Dec 31, 2021 | 26.20% |
| Sep 30, 2021 | 28.08% |
| Jun 30, 2021 | 53.49% |